A non-surgical orthopaedic practice with offices in Cary and Raleigh, North Carolina, offering fat-derived cell therapy and high-dose platelet injections for arthritis and sports injuries.
Carolina Nonsurgical Orthopedics is a private practice that, according to its site, was established in 2013 and treats joint and soft tissue problems without surgery. It runs two offices, one in Cary and one in Raleigh; this entry covers the Cary office at 1010 High House Road. The practice is staffed by non-surgical orthopaedic physicians rather than surgeons, and it states that most major insurances are accepted, which is unusual in this sector and worth noting — although that is likely to apply to conventional care rather than to cell treatments.
The practice's main cell treatment is what it calls microfragmented adipose tissue therapy, generally abbreviated to MFAT. According to the site the tissue is obtained through a minimally invasive mini-liposuction, and the fat is then concentrated and mechanically broken down rather than cultured. The material is therefore autologous (from the patient's own body). The site states that the preparation contains mesenchymal stem cells, growth factors, cytokines and extracellular matrix components, and explains that it cannot quantify how many stem cells are present because United States regulation limits processing to minimal manipulation and does not permit culturing. Alongside this it offers platelet rich plasma (PRP, prepared from the patient's own blood), including formulations it markets as high-dose and as an enhanced version combining plasma proteins and hyaluronic acid.
The practice is comparatively candid about limits. The site makes favourable claims — it refers to high success rates, relief lasting up to two to three years in supporting studies, and the creation of a cellular cushion for joints — and a reader should treat those as the clinic's own marketing rather than established fact. But it also states that there are no large studies confirming that these cells regrow cartilage, and that it will never promise patients they will avoid surgery forever. Those two admissions are more than most comparable sites offer, and they are worth weighing.
Beyond cell and platelet work the practice offers image-guided steroid injections, sports medicine care, post-surgical pain management, lavage for calcific tendonitis, cyst drainage, hydrodilatation for frozen shoulder, and on-site X-ray and ultrasound. The conditions named are arthritis and sports injuries across the knee, hip, shoulder, elbow, hand, wrist, ankle and foot, with the fat-derived cell therapy used mainly for knee arthritis and bone-on-bone knee pain, and sometimes for the hip and shoulder or for large tendon tears.
The site lists joint and soft tissue problems by diagnosis and by body region, and is specific about which ones the fat-derived cell therapy is used for.
The site states that its cell treatment uses the patient's own fat, taken by mini-liposuction and then concentrated and mechanically broken down rather than cultured, and that the resulting preparation contains mesenchymal stem cells along with growth factors, cytokines and extracellular matrix.
Two non-surgical orthopaedic physicians and a physician associate are named on the practice's team page; neither physician is a surgeon.
The Cary office is at 1010 High House Road, Suite 102, Cary, North Carolina 27513, one of two offices the practice runs alongside Raleigh. It is presented as an outpatient clinic with on-site X-ray and diagnostic ultrasound, where injections and the mini-liposuction harvest are carried out in the clinic rather than in a hospital theatre. Fat is processed mechanically on the day rather than sent to a laboratory for culture. The site names certified medical assistants, one with a phlebotomy certification, among its clinical staff. No accreditation or inspection details are published and no languages are mentioned.
The site does not publish prices for cell therapy or platelet injections. It states that most major insurances are accepted, which in practice is likely to cover conventional consultations, imaging and steroid injections rather than the fat-derived cell therapy, since such treatments are generally self-funded in the United States. A prospective patient should ask for a written price for the cell therapy specifically and confirm separately what insurance will pay.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.